Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Resources Corporation stock logo
AREC
American Resources
$1.30
+3.2%
$1.01
$0.38
$1.68
$101.45M0.892.47 million shs2.58 million shs
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
$3.16
+2.6%
$2.58
$0.85
$3.33
$115.84M-0.09207,287 shs59,716 shs
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
$24.53
-0.4%
$24.73
$21.10
$26.49
$392.89M0.64135,373 shs127,545 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Resources Corporation stock logo
AREC
American Resources
+3.17%+16.07%+51.32%+53.72%+152.67%
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
+2.60%+17.04%+9.34%+117.93%+216.00%
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
-0.43%-0.57%-2.18%+4.48%+11.26%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Resources Corporation stock logo
AREC
American Resources
2.4797 of 5 stars
3.53.00.00.02.50.80.6
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
2.5398 of 5 stars
3.55.00.00.01.11.70.0
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
1.5175 of 5 stars
1.03.01.70.02.40.81.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Resources Corporation stock logo
AREC
American Resources
3.00
Buy$4.00207.69% Upside
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
3.00
Buy$7.00121.52% Upside
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
2.00
Hold$24.25-1.15% Downside

Current Analyst Ratings Breakdown

Latest APTA, OKYO, SAR, and AREC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2025
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
Compass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$25.25 ➝ $24.25
5/13/2025
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$23.50
5/12/2025
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
(Data available from 8/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Resources Corporation stock logo
AREC
American Resources
$380K275.43N/AN/A($1.06) per share-1.23
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
N/AN/AN/AN/A($0.16) per shareN/A
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
$148.85M2.63$2.71 per share9.05$27.37 per share0.90
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Resources Corporation stock logo
AREC
American Resources
-$40.11M-$0.49N/A21.67N/A-12,881.75%N/A-20.29%8/18/2025 (Estimated)
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
-$4.71MN/A0.00N/AN/AN/AN/AN/A8/12/2025 (Estimated)
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
$28.09M$2.479.938.23N/A24.85%12.71%4.04%10/14/2025 (Estimated)

Latest APTA, OKYO, SAR, and AREC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/18/2025Q2 2025
American Resources Corporation stock logo
AREC
American Resources
-$0.05N/AN/AN/A$16.40 millionN/A
7/8/2025Q1 2026
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
$0.69$0.66-$0.03$0.91$32.75 million$35,219.96 billion
6/10/2025Q4 2024
American Resources Corporation stock logo
AREC
American Resources
-$0.05-$0.24-$0.19-$0.24$1.30 million$0.05 million
5/19/2025Q4 2024
American Resources Corporation stock logo
AREC
American Resources
N/A-$0.24N/A-$0.24N/A$0.05 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Resources Corporation stock logo
AREC
American Resources
N/AN/AN/AN/AN/A
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
N/AN/AN/AN/AN/A
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
$3.0012.23%N/A121.46%N/A

Latest APTA, OKYO, SAR, and AREC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/16/2025
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
monthly$0.2512.3%9/4/20259/4/20259/24/2025
6/13/2025
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
monthly$0.2512.3%9/4/20259/4/20259/24/2025
8/1/2025
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
$0.2512.17%8/6/20258/7/20258/21/2025
7/1/2025
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
quarterly$0.2512.1%7/8/20257/8/20257/24/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Resources Corporation stock logo
AREC
American Resources
N/A
0.10
0.09
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
N/A
0.40
0.40
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
0.18
0.32
0.32

Institutional Ownership

CompanyInstitutional Ownership
American Resources Corporation stock logo
AREC
American Resources
9.32%
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
2.97%
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
19.09%

Insider Ownership

CompanyInsider Ownership
American Resources Corporation stock logo
AREC
American Resources
16.80%
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
40.46%
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
12.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Resources Corporation stock logo
AREC
American Resources
1080.51 million66.99 millionOptionable
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
737.61 million22.39 millionNot Optionable
Saratoga Investment Corp stock logo
SAR
Saratoga Investment
3,21115.95 million13.79 millionOptionable

Recent News About These Companies

Saratoga US Government Money Mkt I SGMXX - Morningstar

New MarketBeat Followers Over Time

Media Sentiment Over Time

American Resources stock logo

American Resources NASDAQ:AREC

$1.30 +0.04 (+3.17%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$1.32 +0.02 (+1.92%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

American Resources Corporation, together with its subsidiaries, extracts, processes, transports, and sells metallurgical coal to the steel and industrial industries. It supplies raw materials; and sells coal used in pulverized coal injections. The company was founded in 2006 and is headquartered in Fishers, Indiana.

OKYO Pharma stock logo

OKYO Pharma NASDAQ:OKYO

$3.16 +0.08 (+2.60%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$3.20 +0.04 (+1.42%)
As of 08/7/2025 06:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic chronic pain. The company was incorporated in 2007 and is headquartered in London, the United Kingdom.

Saratoga Investment stock logo

Saratoga Investment NYSE:SAR

$24.53 -0.10 (-0.39%)
Closing price 08/7/2025 03:59 PM Eastern
Extended Trading
$24.54 +0.01 (+0.03%)
As of 08/7/2025 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Saratoga Investment Corp. is a business development company specializing in leveraged and management buyouts, acquisition financings, growth financings, recapitalization, debt refinancing, and transitional financing transactions at the lower end of middle market companies. It structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, co-investments, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity. The firm prefers to invest in aerospace, automotive aftermarket and services, business products and services, consumer products and services, education, environmental services, industrial services, financial services, food and beverage, healthcare products and services, logistics, distribution, manufacturing, restaurants services, food services, software services, technology services, specialty chemical, media and telecommunications. It seeks to invest in the United States. The firm primarily invests $5 million to $50 million in companies having EBITDA of $2 million or greater and revenues of $8 million to $250 million. The firm prefer to take a majority stake. It invests through direct lending as well as participation in loan syndicates. The firm was formerly known as GSC Investment Corp. Saratoga Investment Corp. was formed on 2007 and is based in New York, New York with an additional office in Florham Park, New Jersey.